Reliance Global Group (EZRA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
6 May, 2026Opening remarks and agenda
Meeting opened with a cautionary statement regarding forward-looking statements and SEC filings.
Introduction of executive team and board members, including CEO, CFO, and other directors.
Notice of meeting and shareholder list confirmed as distributed and available.
Board and executive committee updates
Board nominations included Ezra Beyman, Alex Blumenfrucht, Scott Korman, Ben Fruchtzweig, and Sheldon Brickman for one-year terms.
Shareholder proposals
Four proposals presented: election of directors, ratification of accounting firm, amendment to equity incentive plan, and approval of share issuance for NASDAQ compliance.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Reliance Global Group
- Net loss improved to $1.4M as insurance growth and tech/life sciences investments advanced.EZRA
Q1 20268 May 2026 - Strategic tech expansion, divestitures, and improved financials position for future growth.EZRAQ4 20256 May 2026
- Strategic investment in Innervate Radiopharmaceuticals advances late-stage healthcare platform exposure.EZRAProxy filing4 May 2026
- Annual meeting seeks approval for director elections, equity plan expansion, and major share issuance.EZRAProxy filing23 Mar 2026
- Shareholders will vote on director elections, equity plan expansion, and a $50M share issuance.EZRAProxy Filing12 Mar 2026
- Q2 net loss improved 62%, Spetner deal to double revenue and boost profitability.EZRAQ2 20242 Feb 2026
- Raising $5.3M for growth, tech, and digital assets amid dilution and Nasdaq compliance risks.EZRARegistration Filing23 Jan 2026
- Q3 2024 delivered revenue growth, cost cuts, positive Adjusted EBITDA, and major M&A and tech moves.EZRAQ3 202415 Jan 2026
- Revenue up 2%, net loss down 24%, and tech advances set stage for further growth.EZRAQ4 202426 Dec 2025